Evidence-Based Medicine Guidelines
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Antibiotic Treatment for Febrile Neutropenia in Cancer Patients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients.
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients. Accessed March 27, 2023.
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients
Oral Versus Intravenous Antibiotic Treatment for Febrile Neutropenia in Cancer Patients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
ID - 451517
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
